CRISPR/Cas 9 Gene Editing In Drug Discovery Trends 2016
Publisher:
HTStec Limited This market report summarizes the results of HTStec’s industry-wide global web-based benchmarking survey on CRISPR/Cas 9 gene editing in drug discovery carried out in February 2016. The questionnaire was compiled to meet the needs, requirements and interests of the gene editing reagents vendor community. The objective was to comprehensively document the current use of CRISPR (clustered regularly interspaced short palindromic repeats) and the associated nuclease Cas 9 in gene editing in drug discovery applications and to understand its future impact. Report Table of Contents (TOC) [Click Here to Download PDF File]
|